Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

被引：0
作者：
Arantxazu Isla
Alicia Rodríguez-Gascón
Iñaki F. Trocóniz
Lorea Bueno
María Ángeles Solinís
Javier Maynar
José Ángel Sánchez-Izquierdo
José Luis Pedraz
机构：
[1] University of the Basque Country,Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy
[2] University of Navarra,Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy
[3] Santiago Apóstol Hospital,Intensive Care Unit
[4] Doce de Octubre Hospital,Intensive Care Unit
[5] Paseo de la Universidad no 7,Laboratorio de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia
来源：
Clinical Pharmacokinetics | 2008年 / 47卷
关键词：
Minimum Inhibitory Concentration; Septic Patient; Meropenem; Continuous Renal Replacement Therapy; Patient Type;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and objective: Meropenem is a carbapenem antibacterial frequently prescribed for the treatment of severe infections in critically ill patients, including those receiving continuous renal replacement therapy (CRRT). The objective of this study was to develop a population pharmacokinetic model of meropenem in critically ill patients undergoing CRRT.
引用
收藏
页码：173 / 180
页数：7
相关论文
共 50 条
  • [41] Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients
    Francesca Mattioli
    Carmen Fucile
    Valerio Del Bono
    Valeria Marini
    Andrea Parisini
    Alexandre Molin
    Maria Laura Zuccoli
    Giulia Milano
    Romano Danesi
    Anna Marchese
    Marialuisa Polillo
    Claudio Viscoli
    Paolo Pelosi
    Antonietta Martelli
    Antonello Di Paolo
    European Journal of Clinical Pharmacology, 2016, 72 : 839 - 848
  • [42] Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration
    Ververs, TFT
    van Dijk, A
    Vinks, SATMM
    Blankestijn, PJ
    Savelkoul, TJF
    Meulenbelt, J
    Boereboom, FTJ
    CRITICAL CARE MEDICINE, 2000, 28 (10) : 3412 - 3416
  • [43] Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
    Jang, Soo Min
    Infante, Sergio
    Pour, Amir Abdi
    PHARMACY, 2020, 8 (01)
  • [44] Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients
    Kitzes-Cohen, R
    Farin, D
    Piva, G
    De Myttenaere-Bursztein, SA
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (02) : 105 - 110
  • [45] Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Meropenem in Critically Ill Patients
    Boonpeng, Apinya
    Jaruratanasirikul, Sutep
    Jullangkoon, Monchana
    Samaeng, Maseetoh
    Wattanavijitkul, Thitima
    Bhurayanontachai, Rungsun
    Pattharachayakul, Sutthiporn
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (11)
  • [46] Continuous renal replacement therapy in critically ill neonates
    S Rödi
    G Zobel
    B Urlesberger
    E Ring
    M Kuttnig-Haim
    Critical Care, 2 (Suppl 1):
  • [47] Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study
    Novy, Emmanuel
    Abdul-Aziz, Mohd H.
    Cheng, Vesa
    Burrows, Fay
    Buscher, Hergen
    Corley, Amanda
    Diehl, Arne
    Gilder, Eileen
    Levkovich, Bianca J.
    Mcguinness, Shay
    Ordonez, Jenny
    Parke, Rachael
    Parker, Suzanne
    Pellegrino, Vincent
    Reynolds, Claire
    Rudham, Sam
    Wallis, Steven C.
    Welch, Susan A.
    Fraser, John F.
    Shekar, Kiran
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (01)
  • [48] Serum Cystatin C is Associated with Renal Function Recovery in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Zhang, Z.
    Xu, X.
    Ni, H.
    Jin, N.
    NEPHRON CLINICAL PRACTICE, 2012, 122 (3-4): : 86 - 92
  • [49] Extending the Benefits of Early Mobility to Critically Ill Patients Undergoing Continuous Renal Replacement Therapy The Michigan Experience
    Talley, Cheryl L.
    Wonnacott, Robert O.
    Schuette, Janice K.
    Jamieson, Jill
    Heung, Michael
    CRITICAL CARE NURSING QUARTERLY, 2013, 36 (01) : 89 - 100
  • [50] Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
    Langgartner, Julia
    Vasold, Antje
    Glueck, Thomas
    Reng, Michel
    Kees, Frieder
    INTENSIVE CARE MEDICINE, 2008, 34 (06) : 1091 - 1096
12345